COVID-19 Impact on Global Cholera Vaccine, Market Insights and Forecast to 2026

COVID-19 Impact on Global Cholera Vaccine, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Cholera Vaccine Product Introduction
1.2 Market Segments
1.3 Key Cholera Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cholera Vaccine Market Size Growth Rate by Type
1.4.2 Dukoral
1.4.3 Shanchol
1.4.4 Vaxchora
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cholera Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cholera Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Cholera Vaccine Industry
1.6.1.1 Cholera Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cholera Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cholera Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Cholera Vaccine Market Size Estimates and Forecasts
2.1.1 Global Cholera Vaccine Revenue 2015-2026
2.1.2 Global Cholera Vaccine Sales 2015-2026
2.2 Cholera Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Cholera Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cholera Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cholera Vaccine Competitor Landscape by Players
3.1 Cholera Vaccine Sales by Manufacturers
3.1.1 Cholera Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Cholera Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Cholera Vaccine Revenue by Manufacturers
3.2.1 Cholera Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cholera Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cholera Vaccine Revenue in 2019
3.2.5 Global Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cholera Vaccine Price by Manufacturers
3.4 Cholera Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cholera Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Cholera Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cholera Vaccine Market Size by Type (2015-2020)
4.1.1 Global Cholera Vaccine Sales by Type (2015-2020)
4.1.2 Global Cholera Vaccine Revenue by Type (2015-2020)
4.1.3 Cholera Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cholera Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Cholera Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Cholera Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Cholera Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cholera Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Cholera Vaccine Market Size by Application (2015-2020)
5.1.1 Global Cholera Vaccine Sales by Application (2015-2020)
5.1.2 Global Cholera Vaccine Revenue by Application (2015-2020)
5.1.3 Cholera Vaccine Price by Application (2015-2020)
5.2 Cholera Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Cholera Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Cholera Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Cholera Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cholera Vaccine by Country
6.1.1 North America Cholera Vaccine Sales by Country
6.1.2 North America Cholera Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cholera Vaccine Market Facts & Figures by Type
6.3 North America Cholera Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Cholera Vaccine by Country
7.1.1 Europe Cholera Vaccine Sales by Country
7.1.2 Europe Cholera Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cholera Vaccine Market Facts & Figures by Type
7.3 Europe Cholera Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cholera Vaccine by Region
8.1.1 Asia Pacific Cholera Vaccine Sales by Region
8.1.2 Asia Pacific Cholera Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cholera Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Cholera Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cholera Vaccine by Country
9.1.1 Latin America Cholera Vaccine Sales by Country
9.1.2 Latin America Cholera Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cholera Vaccine Market Facts & Figures by Type
9.3 Central & South America Cholera Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cholera Vaccine by Country
10.1.1 Middle East and Africa Cholera Vaccine Sales by Country
10.1.2 Middle East and Africa Cholera Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cholera Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Cholera Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Valneva
11.1.1 Valneva Corporation Information
11.1.2 Valneva Description, Business Overview and Total Revenue
11.1.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Valneva Cholera Vaccine Products Offered
11.1.5 Valneva Recent Development
11.2 PaxVax
11.2.1 PaxVax Corporation Information
11.2.2 PaxVax Description, Business Overview and Total Revenue
11.2.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PaxVax Cholera Vaccine Products Offered
11.2.5 PaxVax Recent Development
11.3 Shantha Biotechnics Limited
11.3.1 Shantha Biotechnics Limited Corporation Information
11.3.2 Shantha Biotechnics Limited Description, Business Overview and Total Revenue
11.3.3 Shantha Biotechnics Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shantha Biotechnics Limited Cholera Vaccine Products Offered
11.3.5 Shantha Biotechnics Limited Recent Development
11.4 Celldex Therapeutics
11.4.1 Celldex Therapeutics Corporation Information
11.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
11.4.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celldex Therapeutics Cholera Vaccine Products Offered
11.4.5 Celldex Therapeutics Recent Development
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description, Business Overview and Total Revenue
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Cholera Vaccine Products Offered
11.5.5 Merck Recent Development
11.6 Ceva Asia
11.6.1 Ceva Asia Corporation Information
11.6.2 Ceva Asia Description, Business Overview and Total Revenue
11.6.3 Ceva Asia Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ceva Asia Cholera Vaccine Products Offered
11.6.5 Ceva Asia Recent Development
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description, Business Overview and Total Revenue
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Cholera Vaccine Products Offered
11.7.5 Sanofi Recent Development
11.1 Valneva
11.1.1 Valneva Corporation Information
11.1.2 Valneva Description, Business Overview and Total Revenue
11.1.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Valneva Cholera Vaccine Products Offered
11.1.5 Valneva Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cholera Vaccine Market Estimates and Projections by Region
12.1.1 Global Cholera Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Cholera Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Cholera Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Cholera Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Cholera Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Cholera Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Cholera Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Cholera Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cholera Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cholera Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cholera Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cholera Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Cholera Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Cholera Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Cholera Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cholera Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cholera Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cholera Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cholera Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cholera Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cholera Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Cholera Vaccine Market Segments
Table 2. Ranking of Global Top Cholera Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cholera Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Dukoral
Table 5. Major Manufacturers of Shanchol
Table 6. Major Manufacturers of Vaxchora
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Cholera Vaccine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Cholera Vaccine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Cholera Vaccine Players to Combat Covid-19 Impact
Table 13. Global Cholera Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Cholera Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Cholera Vaccine Sales by Regions 2015-2020 (K Units)
Table 16. Global Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 17. Global Cholera Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Cholera Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Cholera Vaccine Sales Share by Manufacturers (2015-2020)
Table 20. Global Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Cholera Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccine as of 2019)
Table 22. Cholera Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Cholera Vaccine Price (2015-2020) (USD/Unit)
Table 25. Cholera Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Cholera Vaccine Product Type
Table 27. Date of International Manufacturers Enter into Cholera Vaccine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 30. Global Cholera Vaccine Sales Share by Type (2015-2020)
Table 31. Global Cholera Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Cholera Vaccine Revenue Share by Type (2015-2020)
Table 33. Cholera Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 35. Global Cholera Vaccine Sales Share by Application (2015-2020)
Table 36. North America Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 37. North America Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 38. North America Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 40. North America Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 41. North America Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 42. North America Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 43. North America Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 44. Europe Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 45. Europe Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 46. Europe Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 48. Europe Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 49. Europe Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 50. Europe Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 51. Europe Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Cholera Vaccine Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Cholera Vaccine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Cholera Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Cholera Vaccine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 60. Latin America Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 61. Latin America Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 65. Latin America Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 66. Latin America Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 67. Latin America Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 76. Valneva Corporation Information
Table 77. Valneva Description and Major Businesses
Table 78. Valneva Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Valneva Product
Table 80. Valneva Recent Development
Table 81. PaxVax Corporation Information
Table 82. PaxVax Description and Major Businesses
Table 83. PaxVax Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. PaxVax Product
Table 85. PaxVax Recent Development
Table 86. Shantha Biotechnics Limited Corporation Information
Table 87. Shantha Biotechnics Limited Description and Major Businesses
Table 88. Shantha Biotechnics Limited Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Shantha Biotechnics Limited Product
Table 90. Shantha Biotechnics Limited Recent Development
Table 91. Celldex Therapeutics Corporation Information
Table 92. Celldex Therapeutics Description and Major Businesses
Table 93. Celldex Therapeutics Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Celldex Therapeutics Product
Table 95. Celldex Therapeutics Recent Development
Table 96. Merck Corporation Information
Table 97. Merck Description and Major Businesses
Table 98. Merck Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Merck Product
Table 100. Merck Recent Development
Table 101. Ceva Asia Corporation Information
Table 102. Ceva Asia Description and Major Businesses
Table 103. Ceva Asia Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Ceva Asia Product
Table 105. Ceva Asia Recent Development
Table 106. Sanofi Corporation Information
Table 107. Sanofi Description and Major Businesses
Table 108. Sanofi Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Sanofi Product
Table 110. Sanofi Recent Development
Table 111. Global Cholera Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global Cholera Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Cholera Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Cholera Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Cholera Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: Cholera Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Cholera Vaccine Players
Table 129. Cholera Vaccine Customers List
Table 130. Cholera Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholera Vaccine Product Picture
Figure 2. Global Cholera Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Dukoral Product Picture
Figure 4. Shanchol Product Picture
Figure 5. Vaxchora Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cholera Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Cholera Vaccine Report Years Considered
Figure 12. Global Cholera Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global Cholera Vaccine Sales 2015-2026 (K Units)
Figure 14. Global Cholera Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Cholera Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Cholera Vaccine Sales Market Share by Region in 2019
Figure 17. Global Cholera Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Cholera Vaccine Revenue Market Share by Region in 2019
Figure 19. Global Cholera Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Cholera Vaccine Revenue in 2019
Figure 21. Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Cholera Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global Cholera Vaccine Sales Market Share by Type in 2019
Figure 24. Global Cholera Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global Cholera Vaccine Revenue Market Share by Type in 2019
Figure 26. Global Cholera Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global Cholera Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global Cholera Vaccine Sales Market Share by Application in 2019
Figure 29. Global Cholera Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global Cholera Vaccine Revenue Market Share by Application in 2019
Figure 31. North America Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Cholera Vaccine Sales Market Share by Country in 2019
Figure 34. North America Cholera Vaccine Revenue Market Share by Country in 2019
Figure 35. U.S. Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Cholera Vaccine Market Share by Type in 2019
Figure 40. North America Cholera Vaccine Market Share by Application in 2019
Figure 41. Europe Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Cholera Vaccine Sales Market Share by Country in 2019
Figure 44. Europe Cholera Vaccine Revenue Market Share by Country in 2019
Figure 45. Germany Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Cholera Vaccine Market Share by Type in 2019
Figure 56. Europe Cholera Vaccine Market Share by Application in 2019
Figure 57. Asia Pacific Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Cholera Vaccine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Cholera Vaccine Revenue Market Share by Region in 2019
Figure 61. China Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Cholera Vaccine Market Share by Type in 2019
Figure 84. Asia Pacific Cholera Vaccine Market Share by Application in 2019
Figure 85. Latin America Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Cholera Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Cholera Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Cholera Vaccine Market Share by Type in 2019
Figure 96. Latin America Cholera Vaccine Market Share by Application in 2019
Figure 97. Middle East and Africa Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Cholera Vaccine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Cholera Vaccine Revenue Market Share by Country in 2019
Figure 101. Turkey Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Cholera Vaccine Market Share by Type in 2019
Figure 108. Middle East and Africa Cholera Vaccine Market Share by Application in 2019
Figure 109. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. PaxVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shantha Biotechnics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Ceva Asia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs